Merck
MRK
#62
Rank
A$376.46 B
Marketcap
A$150.72
Share price
1.30%
Change (1 day)
-3.39%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): A$11.82

According to Merck's latest financial reports the company's current EPS (TTM) is A$11.41. In 2024 the company made an earnings per share (EPS) of A$10.16 an increase over its 2023 EPS that were of A$0.23.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$11.8216.39%
2024A$10.164308.46%
2023A$0.23-97.32%
2022A$8.6110.92%
2021A$7.7684.68%
2020A$4.20-27.2%
2019A$5.7763.44%
2018A$3.53151.11%
2017A$1.41-54.58%
2016A$3.1030.21%
2015A$2.38-61.99%
2014A$6.26180.51%
2013A$2.23-31.82%
2012A$3.276.62%
2011A$3.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$2.58-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$15.69 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$30.83 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.46-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$5.57-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
A$5.40-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$0.95-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
A$11.06-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
A$12.11 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$19.58 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA